Greenway Announces Third Quarter Financial Statements
MWN-AI** Summary
Greenway Greenhouse Cannabis Corporation (CSE: GWAY) recently announced its financial results for the third quarter ended December 31, 2025, showcasing significant growth and operational improvements. The company recorded net cannabis revenue of CAD 2,348,797, a remarkable 40% increase from the previous year’s CAD 1,676,721. The average net sales price per gram slightly decreased to CAD 1.51, but overall revenue for the first nine months rose to CAD 6,062,528.
A highlight of Greenway's performance this quarter was a significant reduction in cash cost per gram sold, which declined to CAD 0.92 compared to CAD 1.03 a year ago. This cost efficiency contributed to a higher gross profit of CAD 680,589, up from CAD 249,197 in Q3 2025, marking a gross margin improvement from 15% to 29%. Additionally, the company's adjusted EBITDA reached CAD 399,738, showcasing continuous profitability with positive results for five consecutive quarters.
CEO Jamie D'Alimonte emphasized the company's ongoing strategy to enhance operational scale and strengthen customer relationships, which has resulted in a healthy working capital position exceeding CAD 4.5 million when combined with finished goods inventory values. The president, Carl Mastronardi, noted that disciplined market execution is yielding sustainable results, and reiterated a focus on efficiently scaling production and optimizing yields moving forward.
Greenway also took steps to engage an external consultant, Abingdon Capital Corporation, issuing 402,549 common shares as part of their advisory services. The financial statements are accessible on the company's SEDAR profile for further details.
MWN-AI** Analysis
Greenway Greenhouse Cannabis Corporation's (CSE: GWAY) recent Q3 financial results indicate a clear upward trend, showcasing substantial growth that savvy investors should monitor closely.
The company's net cannabis revenue soared by 40% year-over-year to reach $2,348,797, driven by an improved gross profit margin of 29% compared to 15% in Q3 2025. The decrease in cash cost per gram to $0.92 has played a pivotal role in enhancing profitability. This cost efficiency, alongside a robust gross profit of $680,589, signals that Greenway is managing operational costs effectively while scaling its production capabilities.
Furthermore, the report highlights that Greenway achieved positive adjusted EBITDA for the fifth consecutive quarter, at $399,738, reinforcing the company’s financial stability. With cash reserves at $1,181,770 and significant inventory valued at over $3.3 million, Greenway appears poised for sustained growth. The effective management of working capital signals strong operational health, which can attract investor confidence.
Investors should also consider the broader industry context. As the Canadian cannabis market matures, competitive pressures will heighten. Greenway’s focus on scaling production and optimizing product mix, as noted by President Carl Mastronardi, will be crucial to maintaining a competitive edge. Additionally, the recent issuance of common shares for advisory services will bolster operational liquidity, essential for financing growth initiatives.
Given these factors, investors looking for exposure in the cannabis sector might find Greenway a compelling option. The company’s enhancing profitability metrics, coupled with its strategic focus on efficiency and market demand, indicate that it is well-positioned to capitalize on future opportunities. However, as always, potential investors should conduct thorough due diligence and consider market volatility when making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
KINGSVILLE, ON, Feb. 25, 2026 /CNW/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis for the Canadian market, today filed its unaudited condensed interim financial statements for the three and nine months ended December 31, 2025.
Highlights for the third quarter ended December 31, 2025. All amounts are expressed in Canadian dollars:
- Net cannabis revenue was $2,348,797 (Q3 F2025: $1,676,721), an increase of $672,076 (40%), with an average net sales price per gram of $1.51 (Q3 F2025: $1.58). Net cannabis revenue for the nine months ended December 31, 2025 increased to $6,062,528 (2025 of $5,877,837).
- Cash cost per gram sold decreased to $0.92 (Q3 F2025: $1.03).
- Gross profit improved to $680,589 (Q3 F2025: $249,197) in the quarter. For the 2026 fiscal year, gross profit totals $2,321,996, representing more than a 350% increase compared to the prior year.
- Gross margin improved to 29% (Q3 F2025: 15%).
- The Company generated positive operating income for the fourth consecutive quarter.
- Adjusted EBITDA was $399,738 (Q3 F2025: $85,758) an increase of $313,980, representing the fifth consecutive quarter of positive adjusted EBITDA.
- Finished goods inventory totaled 3,053,665 grams valued at $3,377,433, supporting anticipated customer demand requirements.
- Cash was $1,181,770 at quarter end; working capital (excluding amounts due to related parties) amounted to $5,819,285.
Jamie D'Alimonte, CEO of Greenway said: "We are pleased to report our Q3 results which delivered revenue growth of 40% year-over-year, expanding margins, and our fifth consecutive quarter of positive adjusted EBITDA. Our quarter end cash plus the value of finished goods inventory total more than $4.5 million, giving us a healthy working capital position and inventory to support anticipated demand for our high quality product. Our results reflect a business that is gaining scale, improving unit economics, and strengthening strategic customer relationships.
"Our objective is clear: to build a resilient, high-quality cannabis platform capable of generating consistent returns through industry cycles."
"Our production team was able to reduce cash cost per gram over 10%, to $0.92 from $1.03 a year ago. We are demonstrating that disciplined execution in this market drives durable results," said Carl Mastronardi, President of Greenway. "As we move forward, our focus remains on scaling production efficiently, optimizing yields, and enhancing product mix to ensure we continue building momentum across the platform."
Issuance of Shares
The Company is pleased to announce that, pursuant to its engagement letter dated June 4, 2024, with Abingdon Capital Corporation, an arm's length consultant (the "Consultant"), the Company has issued the Consultant and its assignees an aggregate of 402,549 common shares in the capital of the Company (the "Common Shares") at deemed prices between $0.15 and $0.25 per Common Share. The Common Shares were issued in satisfaction of a portion of the monthly work fee owed to the Consultant as consideration for the provision of corporate-finance advisory services. All Common Shares issued will be subject to a hold period of four months and a day from the date of issuance in accordance with applicable CSE policies and Canadian securities laws.
A copy of the interim financial statements for the quarter ended December 31, 2025 (prepared in accordance with IFRS Accounting Standards ("IFRS")) and the related Management's Discussion and Analysis are available under the Company's profile on www.sedarplus.ca.
Non-IFRS Measures
Management uses a non-IFRS measure to assess the Company's performance. Non-IFRS measures do not have any standardized meaning under IFRS and are not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies. Please refer to page 1 of the Company's Management's Discussion and Analysis for an explanation of the composition of Adjusted EBITDA, an explanation of how it provides useful information to an investor and a quantitative reconciliation to the most directly comparable financial measure under IFRS, all of which is hereby incorporated by reference in this press release.
Reconciliations of Non-IFRS Measures
The following table reconciles the non-IFRS measure to the most comparable IFRS measure for the quarter ended December 31, 2025. This measure does not have any standardized meaning under IFRS and is not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies.
For the three months ended December 31, 2025 | ||
Net Loss and Comprehensive Loss | $(134,975) | |
Amortization - Cost of sales | 306,305 | |
Fair value adjustment on sale of inventory Fair value adjustment on growth of biological assets | 2,346 (78,893) | |
Amortization – Operating expenses Shares issued for services rendered | 82,883 76,275 | |
Interest expense | 222,070 | |
Adjusted EBITDA | 399,738 |
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), or any state securities laws and may not be offered or sold in the United States unless registered under the 1933 Act and any applicable securities laws of any state of the United States or an applicable exemption from the registration requirements is available.
Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ontario, and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. More information can be found on Greenway.ca and updates can be followed on Instagram, Twitter, Facebook, and LinkedIn.
The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements, and the Company's beliefs, plans, expectations, future, strategy, objectives, goals and targets, the development of future operations, and orientations regarding the future as of the date of this news release. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward- looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.
Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements, and includes those risks described in the Company's final prospectus dated September 3, 2021, a copy of which is available under the Company's profile at www.sedarplus.ca. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.
SOURCE Greenway Greenhouse Cannabis Corporation
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2026/25/c1914.html
FAQ**
How does Greenway Greenhouse GWAYF plan to maintain its impressive 40% revenue growth amidst potential market fluctuations in the cannabis industry?
What specific strategies is Greenway Greenhouse GWAYF employing to further reduce the cash cost per gram sold while ensuring product quality remains high?
Can Greenway Greenhouse GWAYF provide more insight into the factors that have contributed to sustaining positive adjusted EBITDA for five consecutive quarters?
With a significant increase in gross profit and margin, how does Greenway Greenhouse GWAYF intend to reinvest these earnings to support future growth and scale operations effectively?
**MWN-AI FAQ is based on asking OpenAI questions about Greenway Greenhouse (OTC: GWAYF).
NASDAQ: GWAYF
GWAYF Trading
0.0% G/L:
$0.1085 Last:
5,000 Volume:
$0.1085 Open:
